WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2024)
Top pharmaceutical stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
NBIX
NEUROCRINE BIOSCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$14.66B$145.691.08%$497.00M38.64x0.46
AMPH
AMPHASTAR PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.94B$39.61-0.35%$248.86M12.38x1.34
COLL
COLLEGIUM PHARMACEUTICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.06B$32.360.84%$358.62M11.52x4.02
PCRX
PACIRA BIOSCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$901.60M$19.37-4.20%$190.25M12.74x0.78
ANIP
ANI PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.30B$62.191.37%$128.31M38.39x0.97
SIGA
SIGA TECHNOLOGIES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$663.57M$9.332.98%$102.76M8.48x0.47
LNTH
LANTHEUS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$8.10B$116.790.91%$674.08M17.33x0.94
RDY
DR REDDYS LABORATORIES LTD
NYSE
Drug Manufacturers - Specialty & Generic
$13.03B$78.12-1.15%$1.06B19.45x0.38
KMDA
KAMADA LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$332.23M$5.78-0.86%$26.45M23.12x0.39
ZTS
ZOETIS INC
NYSE
Drug Manufacturers - Specialty & Generic
$81.49B$178.58-0.36%$3.72B34.41x1.84
SCYX
SCYNEXIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$80.47M$2.131.91%$104.31M1.00x0.60
DVAX
DYNAVAX TECHNOLOGIES CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.34B$10.25-1.63%$22.19M146.43x0.60
ITCI
INTRA-CELLULAR THERAPIES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$7.90B$74.86-0.11%-$109.36M-64.53x0.25
HCM
HUTCHMED (CHINA) LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$3.30B$18.94-1.30%N/A31.57x0.73
ALKS
ALKERMES PLC
NASDAQ
Drug Manufacturers - Specialty & Generic
$4.20B$24.830.73%$438.76M9.48x0.69
CRON
CRONOS GROUP INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$909.19M$2.381.28%-$106.26M-17.00x0.03
PAHC
PHIBRO ANIMAL HEALTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$754.99M$18.64-1.01%$79.80M56.48x2.63
TLRY
TILRAY BRANDS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.39B$1.79-2.19%-$186.62M-4.07x0.26
EOLS
EVOLUS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$748.82M$11.961.96%-$38.05M-11.50x11.26
ETON
ETON PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$89.92M$3.502.34%$1.48M87.50x0.99
SBFM
SUNSHINE BIOPHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$5.57M$0.29-2.65%-$3.41M-0.02x0.29
PBH
PRESTIGE CONSUMER HEALTHCARE INC
NYSE
Drug Manufacturers - Specialty & Generic
$3.56B$71.24-0.46%$380.01M16.92x1.01
ZOM
ZOMEDICA CORP
NYSEMKT
Drug Manufacturers - Specialty & Generic
$145.03M$0.15-1.33%-$37.34M-3.89x0.05
PETQ
PETIQ INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$635.80M$21.37-1.61%$86.37M85.48x2.70
HLN
HALEON PLC
NYSE
Drug Manufacturers - Specialty & Generic
$41.14B$8.910.00%$2.70B30.83x1.04
TLPH
TALPHERA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$14.78M$0.871.16%-$13.69M-1.02x0.76
PROC
PROCAPS GROUP SA
NASDAQ
Drug Manufacturers - Specialty & Generic
$270.78M$2.400.00%$75.58M4.62x11.68
UPC
UNIVERSE PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$13.53M$3.71-6.08%-$3.18M-2.18x0.35
OPTN
OPTINOSE INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$119.82M$1.06-1.85%-$10.52M-3.93x-1.84
TXMD
THERAPEUTICSMD INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$21.22M$1.841.66%-$6.47M-2.71x0.47
ORGO
ORGANOGENESIS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$384.46M$2.90-1.36%$36.49M72.50x0.65
TKNO
ALPHA TEKNOVA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$88.59M$2.1714.21%-$29.00M-2.09x0.45
EGRX
EAGLE PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$76.23M$5.871.91%$57.18M6.38x0.61
ESPR
ESPERION THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$452.81M$2.39-2.45%-$27.81M-2.46x-2.27
YCBD
CBDMD INC
NYSEMKT
Drug Manufacturers - Specialty & Generic
$2.32M$0.60-3.23%-$18.76M-0.05x3.71
ACB
AURORA CANNABIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$313.64M$5.750.00%-$25.92M-1.14x0.42
HROW
HARROW INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$884.90M$25.011.71%$4.49M-27.18x3.89
EVOK
EVOKE PHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$4.57M$0.53-2.57%-$6.54M-0.29x2.56
AVDL
AVADEL PHARMACEUTICALS PLC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.56B$16.201.63%-$145.72M-8.85x1.14
PRGO
PERRIGO CO PLC
NYSE
Drug Manufacturers - Specialty & Generic
$3.82B$28.001.27%$405.80M-466.67x1.27
ASRT
ASSERTIO HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$156.00M$1.640.61%-$222.38M-0.45x1.10
ALIM
ALIMERA SCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$291.80M$5.57-0.18%$2.05M-4.53x2.75
RMTI
ROCKWELL MEDICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$58.21M$1.921.05%-$2.20M-5.33x1.46
TAK
TAKEDA PHARMACEUTICAL CO LTD
NYSE
Drug Manufacturers - Specialty & Generic
$41.92B$13.36-0.96%$6.34B45.75x1.08
ALVO
ALVOTECH
NASDAQ
Drug Manufacturers - Specialty & Generic
$3.19B$11.940.25%-$300.48M-5.74x-2.61
INCR
INTERCURE LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$104.82M$2.300.88%-$10.66M-6.34x0.72
AQST
AQUESTIVE THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$291.32M$3.204.58%-$17.12M-7.44x-4.57
HUGE
FSD PHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$5.58M$0.14-3.50%-$6.09M-0.73x0.33
DERM
JOURNEY MEDICAL CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$109.27M$5.46-0.91%$1.26M-27.30x4.14
SNOA
SONOMA PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$5.78M$0.31-8.61%-$4.86M-0.58x1.40
FLGC
FLORA GROWTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$13.84M$1.08-0.46%-$55.83M-0.14x6.74
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$44.26M$6.1915.06%-$6.52M-5.63x0.16
RDHL
REDHILL BIOPHARMA LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$13.88M$0.36-2.16%$14.62M0.09x10.14
GHSI
GUARDION HEALTH SCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$12.75M$9.933.52%-$5.10M-2.47x2.05
DRRX
DURECT CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$49.35M$1.599.66%-$20.65M-1.92x3.36
AYTU
AYTU BIOPHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$15.54M$2.79-2.11%-$4.17M-1.14x3.19
PTPI
PETROS PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$3.01M$0.433.61%-$5.12M-0.06x2.01
SUPN
SUPERNUS PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.66B$30.253.95%$79.91M-104.31x0.40
BFRI
BIOFRONTERA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$5.14M$1.01-1.94%-$20.14M-0.10x-4.88
SXTC
CHINA SXT PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$793.36k$1.09-0.82%-$13.36M-0.04x1.87
CTLT
CATALENT INC
NYSE
Drug Manufacturers - Specialty & Generic
$10.48B$57.91-0.14%-$524.00M-8.92x1.74
EBS
EMERGENT BIOSOLUTIONS INC
NYSE
Drug Manufacturers - Specialty & Generic
$586.90M$11.20-2.01%-$345.80M-1.02x1.72
CYTH
CYCLO THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$34.63M$1.210.83%-$19.38M-1.21x10.74
INDV
INDIVIOR PLC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.42B$10.41-0.48%$75.00M260.25x144.30
IMCC
IM CANNABIS CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$5.02M$2.25-3.85%-$3.75MN/A3.44
KALA
KALA BIO INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$19.04M$6.76-1.02%-$33.22M-0.45x6.96
CGC
CANOPY GROWTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$543.29M$7.13-1.25%-$435.12M-1.10x1.60
CPIX
CUMBERLAND PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$21.00M$1.482.78%-$1.82M-2.51x1.98
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$44.50M$3.426.54%-$5.10M-7.60x0.05
OGI
ORGANIGRAM HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$155.87M$1.651.85%N/AN/A0.22
LFCR
LIFECORE BIOMEDICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$148.15M$4.85-4.72%-$68.32M-1.46x-51.65
CRDL
CARDIOL THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$133.96M$2.094.50%-$21.87M-6.09x0.55
EVO
EVOTEC SE
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.67B$4.70-1.67%N/AN/A0.98
VTRS
VIATRIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$14.10B$11.840.59%$3.35B-394.67x1.37
PRFX
PAINREFORM LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$934.37k$0.51-3.81%-$12.72M-0.07x1.91
IXHL
INCANNEX HEALTHCARE INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$35.71M$2.25-3.85%N/AN/A0.22
BHC
BAUSCH HEALTH COMPANIES INC
NYSE
Drug Manufacturers - Specialty & Generic
$2.79B$7.602.98%$2.34B-6.18x-24.29
IRWD
IRONWOOD PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.07B$6.721.36%-$977.81M-0.99x-2.33
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
NYSE
Drug Manufacturers - Specialty & Generic
$19.04B$16.812.88%$1.64B-38.20x4.84
AKAN
AKANDA CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$442.14k$2.00-6.54%-$27.74M-0.01x-3.31
CPHI
CHINA PHARMA HOLDINGS INC
NYSEMKT
Drug Manufacturers - Specialty & Generic
$4.02M$0.25-1.94%-$454.86k-0.37x0.95
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$7.73M$0.460.00%-$4.96M-1.00x0.72
ELAN
ELANCO ANIMAL HEALTH INC
NYSE
Drug Manufacturers - Specialty & Generic
$6.29B$12.72-1.17%-$325.00M-4.80x1.32
AMRX
AMNEAL PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.23B$7.24-1.09%$299.04M-9.78x-55.24
BGXX
BRIGHT GREEN CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$42.60M$0.22-0.44%-$10.84M-3.20x0.44

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Jul 2024?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Neurocrine Biosciences (NASDAQ:NBIX)


Neurocrine Biosciences (NASDAQ:NBIX) is the top pharmaceutical stock with a Zen Score of 69, which is 43 points higher than the pharmaceutical industry average of 26. It passed 23 out of 33 due diligence checks and has strong fundamentals. Neurocrine Biosciences has seen its stock return 48.89% over the past year, overperforming other pharmaceutical stocks by 52 percentage points.

Neurocrine Biosciences has an average 1 year price target of $165.50, an upside of 13.6% from Neurocrine Biosciences's current stock price of $145.69.

Neurocrine Biosciences stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Neurocrine Biosciences, 56.25% have issued a Strong Buy rating, 25% have issued a Buy, 18.75% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amphastar Pharmaceuticals (NASDAQ:AMPH)


Amphastar Pharmaceuticals (NASDAQ:AMPH) is the second best pharmaceutical stock with a Zen Score of 66, which is 40 points higher than the pharmaceutical industry average of 26. It passed 22 out of 33 due diligence checks and has strong fundamentals. Amphastar Pharmaceuticals has seen its stock lose -36.45% over the past year, underperforming other pharmaceutical stocks by -34 percentage points.

Amphastar Pharmaceuticals has an average 1 year price target of $65.50, an upside of 65.36% from Amphastar Pharmaceuticals's current stock price of $39.61.

Amphastar Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Amphastar Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the third best pharmaceutical stock with a Zen Score of 59, which is 33 points higher than the pharmaceutical industry average of 26. It passed 19 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 48.92% over the past year, overperforming other pharmaceutical stocks by 52 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $40.75, an upside of 25.93% from Collegium Pharmaceutical's current stock price of $32.36.

Collegium Pharmaceutical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Collegium Pharmaceutical, 50% have issued a Strong Buy rating, 25% have issued a Buy, 25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 6.43%, which is 4 percentage points higher than the pharmaceutical industry average of 2.54%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

2. Alkermes (NASDAQ:ALKS)


Alkermes (NASDAQ:ALKS) has an annual dividend yield of 4.31%, which is 2 percentage points higher than the pharmaceutical industry average of 2.54%.

Alkermes's dividend payout ratio of 40.8% indicates that its high dividend yield is sustainable for the long-term.

3. Perrigo Co (NYSE:PRGO)


Perrigo Co (NYSE:PRGO) has an annual dividend yield of 2.94%, which is the same as the pharmaceutical industry average of 2.54%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -1,825% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 0.28% in the last day, and down -0.89% over the last week. Siga Technologies was the among the top gainers in the drug manufacturers - specialty & generic industry, gaining 2.98% yesterday.

Siga Technologies shares are trading higher after the company announced that the U.S. Department of Health and Human Services exercised a $113 million procurement option for the delivery of oral TPOXX treatment courses.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Collegium Pharmaceutical has a valuation score of 86, which is 69 points higher than the pharmaceutical industry average of 17. It passed 6 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 48.92% in the past year. It has overperformed other stocks in the pharmaceutical industry by 52 percentage points.

2. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Kamada has a valuation score of 71, which is 54 points higher than the pharmaceutical industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Kamada's stock has gained 14.23% in the past year. It has overperformed other stocks in the pharmaceutical industry by 17 percentage points.

3. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 71, which is 54 points higher than the pharmaceutical industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -47.31% in the past year. It has underperformed other stocks in the pharmaceutical industry by -45 percentage points.

Are pharmaceutical stocks a good buy now?

62.75% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 29.91% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -3.43x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.